Home ›
NPI 1003315011
NPI deactivated
1003315011
1003315011 was paid $487K by Medicaid between Jan 2020 and Nov 2023, across 3 billing codes. Its largest line is J2315, Injection, naltrexone, depot form, 1 mg — 100% of everything it billed.
33Billing provider info1003315011
33aNPI1003315011
33bProvider type—
28Total paid$487K
24GClaims509
24DCodes billed3
24AFirst – last monthJan 2020 – Nov 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 36 | $345.09 | |
| 2021 | 42 | $16K | |
| 2022 | 163 | $151K | |
| 2023 | 268 | $320K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2315 | Injection, naltrexone, depot form, 1 mg | 100% | 380 | 324 | $485K |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | <1% | 113 | 98 | $2K |
| M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | <1% | 16 | 16 | $677.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.